Last week, a federal judge ruled that the Food and Drug Administration (FDA) cannot prohibit a pharmaceutical company from marketing its drugs for off-label uses if its claims are truthful and not ...

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Label Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering. The global pharmaceutical label ...

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Labeling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's ...

Resource Label is a national label company Founded in 1986, MedLit is based in New Jersey and North Carolina CORE invests in North American lower middle-market manufacturing, industrial technology, ...

As one long-running feud over the controversial generic drug carveout known as “skinny” labeling comes to a close, the United States’ top lawyer is urging the Supreme Court to reverse a recent ...

Analyst insight: The pharmaceutical industry is making significant progress in standardizing labels and serialization across supply chains. A group of U.S. pharmaceutical and healthcare providers have ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Pharmaceutical manufacturer AstraZeneca, based in Wilmington, Del., has agreed to pay $520 million to settle allegations that it had illegally marketed its antipsychotic drug Seroquel, according to an ...

GW Pharmaceuticals PLC- ADR GWPH shares are retreating following the release of fourth-quarter results. GW Pharmaceuticals reported quarterly losses of 7 cents per share, which beat the consensus ...

Patients rely on drug labels to ensure they're using their medications correctly. When those labels are MIA, recalls are sure to follow. Such is the case with Viatris' Mylan, which said Wednesday it ...

LEO Pharma has submitted a label expansion application to EMA to expand Anzupgo® (delgocitinib) cream to adolescent patients (12–17 years) with moderate to severe chronic hand eczema (CHE) for whom ...